Events Search and Views Navigation

Event Views Navigation

Today

Filter by

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Coffee Sessions
Virtual
Coffee Sessions
Virtual
Event Series Coffee Sessions

Forging Bidirectional Accompaniment in Global Health

Drs. Mukherjee and Manzi will illustrate how bidirectional accompaniment is a cornerstone of success in global health practice, where sharing new skills, tools, and approaches is not an optional endeavor, but a crucial element. The pair will provide concrete examples of how this concept plays out in global health, defining exactly what it looks like as well as what it does not. Dr. Louise Ivers, Faculty Director of the Harvard Global Health Institute, will moderate the discussion. The event is free and open to the public.
Free
Research and Innovation Speaker Series
Virtual
Research and Innovation Speaker Series
Virtual

Coffee Sessions
digital transformation
health justice
Coffee Sessions
digital transformation
health justice
Event Series Coffee Sessions

A Partnership for a Shared Vision of Equity in Global Health

Dr. Jessica Haberer of Harvard Medical School and Professor Yap Boum II of the Institute Pasteur of Bangui will discuss their decade-long collaboration promoting global health equity through advocacy, mentorship, and empowering communities. They will present their new project, "The Village", an AI digital platform connecting researchers, clinicians and institutions worldwide without barriers. Dr. Louise C. Ivers will moderate the conversation. The event is free and open to the public.

Coffee Sessions
health justice
Coffee Sessions
health justice
Event Series Coffee Sessions

Oral Histories, Microsensors, and Parametric Insurance: When Poor Women Workers Drive the Research Agenda

SEWA members, Manshi Shah and Kapilaben Vankar, in conversation with Satchit Balsari, will describe how the 3 million-strong Self Employed Women’s Association has approached academic partnerships. Over 50 years, SEWA has partnered with a range of researchers from India and abroad; and established educational programs and exchanges with local academic institutions. Harvard faculty have collaborated with SEWA for over two decades. In this HGHI Coffee Session, the speakers will describe how a research project examining SEWA’s response to the pandemic evolved into a multi-city traveling exhibition, that will travel from Harvard to New York and DC and then the west coast. They will share how SEWA’s members, most at-risk to extreme heat, are partnering with researchers to inform cutting age climate adaptation products including the world’s first-ever parametric insurance product to protect wages when it’s too hot to work. The speakers will present their vision for what meaningful research partnerships between academic institutions and communities can look like.
Research and Innovation Speaker Series
climate change
Research and Innovation Speaker Series
climate change
infectious disease
infectious disease

H5N1: The Current State of the Avian Flu Outbreak

What is the current public health threat and what response is required to mitigate the H5N1 Avian Influenza Virus outbreak? During this event our speakers will bring expertise in veterinary health, virology, infectious disease, One Health and epidemiology to break down the answers to those questions. In a conversation led by Dr. Louise Ivers, experts will dive into the evolution of prior H5N1 outbreaks and explore why animal to human transmission of viruses poses a real threat to public health.

Coffee Sessions
Coffee Sessions
Event Series Coffee Sessions

Leveraging Partnerships to Improve the Health of Young People Living with HIV in Peru

This event will showcase the essential role of partnerships in designing and evaluating interventions for young people affected by HIV in Peru by spotlighting the successful partnership between Dr. Molly Franke, Associate Professor of Global Health and Social Medicine at the Harvard Medical School, and Dr. Renato Errea, Head of the HIV Program at Socios En Salud. Our speakers will describe the tangible impact their work has had on improving access to HIV care for Peruvian adolescents and will offer valuable insights into how they have navigated complex challenges through a bidirectional partnership. About the HGHI Coffee Sessions The HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health, global health security, mental healthcare, reproductive healthcare access, financing and governance for global health, healthcare in conflict areas, digital health, and more. This series will take place online over Zoom, and all sessions will be recorded and available on HGHI’s YouTube Channel. About our Speakers Molly Franke, SD, Associate Professor and Epidemiologist, Global Health Research Core, Department of Global Health and Social Medicine, Harvard Medical School Dr. Molly Franke is an epidemiologist and Associate Professor in Global Health and Social Medicine at Harvard Medical School. For nearly 20 years she has collaborated with Socios En Salud on research to improve the health of children and adolescents affected by TB and HIV. Her current intervention work includes studies to reduce stigma and improve the well-being of adolescents and young adults living with HIV through the provision of community-based accompaniment and youth-friendly modalities, such as music videos and social media. Renato Errea, MD, MMSc, Head, HIV Program, Socios En Salud Dr. Renato Errea is a Peruvian physician researcher with nearly a decade of experience conducting global health research and interventions focused on people affected by HIV and other vulnerable populations in Peru. Dr. Errea is the Head of the HIV Program at the Peruvian non-governmental organization Socios En Salud. In this role, he leads interventions and studies focused on facilitating access to comprehensive care to the communities most affected by HIV and other prioritized populations in the context of HIV (adolescents and migrants), in Peru.
Research and Innovation Speaker Series
Research and Innovation Speaker Series

Innovation in the Treatment of Drug-resistant Tuberculosis: The endTB Clinical Trial

LEARN MORE/REGISTER In this Global Health Research and Innovations Speaker Series event, Dr. Carole Diane Mitnick, ScD, Professor of Global Health and Social Medicine at Harvard Medical School will share her work on the endTB clinical trial. Dr. Louise C. Ivers, MD, MPH, DTM&H, Faculty Director at the Harvard Global Health Institute, will moderate the conversation. PLEASE CLICK HERE TO REGISTER Event Description For decades, poor treatment options and low-quality evidence plagued care for rifampin-resistant tuberculosis (RR-TB). The advent of new anti-TB drugs and enhanced funding now permit randomized controlled trials of shortened, all-oral treatment for resistant TB. Methods endTB is an international, open-label, Phase 3 non-inferiority, randomized, controlled clinical trial to compare five 9-month all-oral regimens including bedaquiline (B), delamanid (D), linezolid (L), levofloxacin (Lfx) or moxifloxacin (M), clofazimine (C) and pyrazinamide (Z), to the standard (control) for treatment of fluoroquinolone-susceptible RR-TB. Participants were randomized to 9BLMZ, 9BCLLfxZ, 9BDLLfxZ, 9DCLLfxZ, 9DCMZ and control using Bayesian response-adaptive randomization. The primary outcome was favorable outcome at week 73 defined by two negative sputum culture results or by favorable bacteriologic, clinical, and radiologic evolution. The non-inferiority margin was 12 percentage points. Results Of 754 randomized patients, 696 and 559 were included in the modified intention to treat (mITT) and per-protocol (PP) analyses, respectively. In mITT, the control had 80.7% favorable outcomes. Regimens 9BCLLfxZ [adjusted risk difference (aRD): 9.5% (95% confidence interval (CI), 0.4 to 18.6)], 9BLMZ [aRD: 8.8% (95%CI, -0.6 to 18.2)], and 9BDLLfxZ [3.9% (95%CI, -5.8 to 13.6)] were non-inferior in mITT and in PP. The proportion of participants experiencing grade 3 or higher adverse events was similar across the regimens. Grade 3 or higher hepatotoxicity occurred in 11.7% of the experimental regimens overall and in 7.1% of the control. Conclusions The endTB trial increases treatment options for RR-TB with three shortened, all-oral regimens that were non-inferior to a current well-performing standard of care. PLEASE CLICK HERE TO REGISTER About the Speakers Carole Diane Mitnick, ScD, Professor of Global Health and Social Medicine, Harvard Medical School Dr. Mitnick is Professor of Global Health & Social Medicine at Harvard Medical School (HMS) and Associate Epidemiologist in the Division of Global Health Equity at Brigham & Women’s Hospital. She has 25 years of experience in programmatic support, research (observational and experimental), policy, and advocacy related to increased access to high-quality, appropriate treatment for TB, especially for drug-resistant TB. Dr. Mitnick works in close collaboration with Partners In Health, specifically in Peru, Haiti, Kazakhstan, and Lesotho. In addition to teaching at HMS and giving lectures at other institutions, Dr. Mitnick mentors trainees in the HMS Master of Medical Science in Global Health Delivery Program. She is the co-PI of the endTB and endTB-Q trials, two multi-country, Phase III, randomized, controlled, clinical trials of all-oral, shortened, novel regimens for rifampin-resistant TB. She has also recently begun conducting research on post-TB lung disease. Louise C. Ivers, MD, MPH, DTM&H, Faculty Director, Harvard Global Health Institute; Executive Director, Massachusetts General Hospital Center for Global Health Dr. Louise C. Ivers, MD, MPH, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design, implementation, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India, Southeast Asia, and Africa. From 2003-2017, Dr. Ivers served in various leadership roles for Partners in Health, including Clinical Director, Chief of mission, and Director of strategic implementation. In addition to expanding access to healthcare for the poor, Dr. Ivers has contributed to published research articles on HIV/AIDS, food insecurity, and cholera treatment and prevention and is involved in global policy and advocacy. About the Global Health Research and Innovation Speaker Series The Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond, to make cutting-edge research accessible to a diverse global audience, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health, followed by a moderated Q&A. Speakers will share their own perspectives; they do not speak for the university.

Coffee Sessions
leadership
tech and health
Coffee Sessions
leadership
tech and health

Better Evidence, Better Training, Better Care: Supporting current and future clinicians in Africa to use evidence-based digital tools

This session will explore the partnerships and people that enable Better Evidence at Ariadne Labs to support the frontline health workforce to make the best decisions when and where it matters most. Through 108 local Champions, the Better Evidence for Training program is facilitating access to digital tools for nearly 90,000 students and faculty at more than 59 medical schools across 16 countries in sub-Saharan Africa.

2024 Global Health Symposium

The Harvard Global Health Institute’s annual Global Health Symposium provides the opportunity for faculty, staff, and students across Harvard’s schools, institutes, centers, departments, and affiliated hospitals, as well as an international community of health professionals, academics, and civil society, to connect and engage in meaningful conversations around some of the most pressing global health issues in an inclusive hybrid experience. Read more on our 2024 Global Health Symposium webpage.
climate change
fellowship
student engagement
climate change
fellowship
student engagement

Pathways to Global Health: Climate Change and Health

42 Church Street, Cambridge, MA, United States
Join us for this informal in-person session for Harvard undergraduates to connect with our current 2023 HGHI Burke Climate and Health Fellows, Annikki Herranen-Tabibi, PhD, and Jenny Lee, PhD. Learn about their career journeys in the intersection of climate change and health — over pizzas and soft drinks! Annikki Herranen-Tabibi (she/her) is a medical and environmental anthropologist of the Circumpolar Arctic. She is engaged in long-term ethnographic research in Sápmi, the transborder homeland of the Indigenous Sámi people. Her scholarly work defines a space for research and collaborative action at the intersections of global health with medical and environmental humanities and social sciences. Across these arenas, her work is grounded in questions of care – interpersonal, intergenerational, and ecological. Jenny Lee is a Postdoctoral Fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health . She received an M.S. in Biostatistics from Yale University and received her Ph.D. in Biostatistics from Harvard University. Her work has focused on assessing the health impacts of air pollution on vulnerable populations, including pregnant women, children, and the elderly, with an aim to find policy implications that provide actionable insights for policymakers. Her research focuses on developing statistical methods for assessing the impact of exposure to multi-pollutant mixtures during pregnancy on high-dimensional epigenetic markers in newborns, and developing causal inference methods for clustered data in environmental health to assess effects of air pollution on socioeconomically disadvantaged children and elderly in the U.S.
Research and Innovation Speaker Series
Research and Innovation Speaker Series
Event Series Research and Innovation Speaker Series

Research and Innovation Speaker Series

The Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond, to make cutting-edge research accessible to a diverse global audience, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health, followed by a moderated Q&A. Speakers will share their own perspectives; they do not speak for Harvard.